investors.bmrn.com investors.bmrn.com

investors.bmrn.com

BioMarin Pharmaceutical Inc. - Investor Relations

Grants and Charitable Contributions. BioMarin Europe Ltd./BioMarin Latin America. BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the companys common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarins policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly. Aug 5, 2015 - Form S-8.

http://investors.bmrn.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.BMRN.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 14 reviews
5 star
6
4 star
5
3 star
3
2 star
0
1 star
0

Hey there! Start your review of investors.bmrn.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.6 seconds

CONTACTS AT INVESTORS.BMRN.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
BioMarin Pharmaceutical Inc. - Investor Relations | investors.bmrn.com Reviews
<META>
DESCRIPTION
Grants and Charitable Contributions. BioMarin Europe Ltd./BioMarin Latin America. BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the companys common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarins policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly. Aug 5, 2015 - Form S-8.
<META>
KEYWORDS
1 biomarin
2 site map
3 about us
4 message from management
5 leadership team
6 management team
7 board of directors
8 scientific advisory board
9 history
10 naglazyme
CONTENT
Page content here
KEYWORDS ON
PAGE
biomarin,site map,about us,message from management,leadership team,management team,board of directors,scientific advisory board,history,naglazyme,aldurazyme,kuvan,firdapse,trade;,pipeline,clinical trials,achondroplasia,genetically defined cancer,lems,gina
SERVER
Microsoft-IIS/6.0
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

BioMarin Pharmaceutical Inc. - Investor Relations | investors.bmrn.com Reviews

https://investors.bmrn.com

Grants and Charitable Contributions. BioMarin Europe Ltd./BioMarin Latin America. BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the companys common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarins policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly. Aug 5, 2015 - Form S-8.

INTERNAL PAGES

investors.bmrn.com investors.bmrn.com
1

Investor Relations - BioMarin Pharmaceutical Inc.

http://investors.bmrn.com/index.cfm

A Message from the CEO. Dr Henry J. Fuchs. Daniel P. Maher. Joshua A. Grass. Eduardo E. Von Pervieux. Corporate and Social Responsibility. Drisapersen for Duchenne Muscular Dystrophy. Pegvaliase (Peg-Pal) for PKU. Reveglucosidase Alfa (BMN 701): GILT GAA for Pompe Disease. BMN 111: CNP for Achondroplasia. BMN 044 for Duchenne Muscular Dystrophy. BMN 045: for Duchenne Muscular Dystrophy. BMN 053 for Duchenne Muscular Dystrophy. Cerliponase Alfa: (BMN 190)-TPP1 for CLN2 disease. Morquio A (MPS IVA). BioMar...

2

Corporate Governance - BioMarin Pharmaceutical Inc.

http://investors.bmrn.com/governance.cfm

A Message from the CEO. Dr Henry J. Fuchs. Daniel P. Maher. Joshua A. Grass. Eduardo E. Von Pervieux. Corporate and Social Responsibility. Drisapersen for Duchenne Muscular Dystrophy. Pegvaliase (Peg-Pal) for PKU. Reveglucosidase Alfa (BMN 701): GILT GAA for Pompe Disease. BMN 111: CNP for Achondroplasia. BMN 044 for Duchenne Muscular Dystrophy. BMN 045: for Duchenne Muscular Dystrophy. BMN 053 for Duchenne Muscular Dystrophy. Cerliponase Alfa: (BMN 190)-TPP1 for CLN2 disease. Morquio A (MPS IVA). Policy...

3

Press Releases - BioMarin Pharmaceutical Inc.

http://investors.bmrn.com/releases.cfm

A Message from the CEO. Dr Henry J. Fuchs. Daniel P. Maher. Joshua A. Grass. Eduardo E. Von Pervieux. Corporate and Social Responsibility. Drisapersen for Duchenne Muscular Dystrophy. Pegvaliase (Peg-Pal) for PKU. Reveglucosidase Alfa (BMN 701): GILT GAA for Pompe Disease. BMN 111: CNP for Achondroplasia. BMN 044 for Duchenne Muscular Dystrophy. BMN 045: for Duchenne Muscular Dystrophy. BMN 053 for Duchenne Muscular Dystrophy. Cerliponase Alfa: (BMN 190)-TPP1 for CLN2 disease. Morquio A (MPS IVA). SAN RA...

4

Financials & Filings - BioMarin Pharmaceutical Inc.

http://investors.bmrn.com/financials.cfm

A Message from the CEO. Dr Henry J. Fuchs. Daniel P. Maher. Joshua A. Grass. Eduardo E. Von Pervieux. Corporate and Social Responsibility. Drisapersen for Duchenne Muscular Dystrophy. Pegvaliase (Peg-Pal) for PKU. Reveglucosidase Alfa (BMN 701): GILT GAA for Pompe Disease. BMN 111: CNP for Achondroplasia. BMN 044 for Duchenne Muscular Dystrophy. BMN 045: for Duchenne Muscular Dystrophy. BMN 053 for Duchenne Muscular Dystrophy. Cerliponase Alfa: (BMN 190)-TPP1 for CLN2 disease. Morquio A (MPS IVA). Welcom...

5

Events & Presentations - BioMarin Pharmaceutical Inc.

http://investors.bmrn.com/events.cfm

A Message from the CEO. Dr Henry J. Fuchs. Daniel P. Maher. Joshua A. Grass. Eduardo E. Von Pervieux. Corporate and Social Responsibility. Drisapersen for Duchenne Muscular Dystrophy. Pegvaliase (Peg-Pal) for PKU. Reveglucosidase Alfa (BMN 701): GILT GAA for Pompe Disease. BMN 111: CNP for Achondroplasia. BMN 044 for Duchenne Muscular Dystrophy. BMN 045: for Duchenne Muscular Dystrophy. BMN 053 for Duchenne Muscular Dystrophy. Cerliponase Alfa: (BMN 190)-TPP1 for CLN2 disease. Morquio A (MPS IVA). Invest...

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

SOCIAL ENGAGEMENT



OTHER SITES

investors.bldr.com investors.bldr.com

Builders FirstSource, Inc. - Company Highlights

Floyd F. Sherman. Chief Executive Officer and Director. President, Chief Operating Officer and Chief Financial Officer. Donald F. McAleenan. Senior Vice President and General Counsel. Morris E. Tolly. Senior Vice President of Operations. Jul 31, 2015. Builders FirstSource Completes Acquisition of ProBuild. Jul 27, 2015. Builders FirstSource, Inc. Announces Public Offering of Common Stock. Jul 23, 2015. Builders FirstSource Reports Second Quarter 2015 Results. Jul 16, 2015. Jul 13, 2015. As of Aug 14, 2015.

investors.bloominbrands.com investors.bloominbrands.com

Bloomin' Brands, Inc. - Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Bloomin' Brands, Inc.'s financial performance into perspective. Press Releases View all ». Aug 4, 2015. Bloomin' Brands Announces 2015 Second Quarter Adjusted Diluted EPS of $0.28 and Diluted EPS of $0.26;. Jul 7, 2015. Bloomin' Brands, Inc. to Host Fiscal 2015 Second Quarter Earnings Conference Call at 9:00 AM ET on August 4, 2015. May 22, 2015.

investors.blox.ua investors.blox.ua

investors guide

Куда обратить особое внимание . Цель по выбору нужного . Коротко про онлайн магазин. Race Touareg 3 Qatar. Понеділок, 03.08.2015. Ключовим фактором, який може ефективно стримувати девальвацію гривні, залишається реструктуризація зовнішнього держборгу і боргу держкомпаній. Сама по собі ідея знімає навантаження на платіжний баланс. А з урахуванням того, що за прикладом держави вже пішов великий приватний бізнес (Метінвест, Ferrexpo, Приватбанк та інші великі позичальники), аналітики все частіше зад...Данна...

investors.blue-bird.com investors.blue-bird.com

Company Overview | Blue-Bird

All American FE - Diesel. All American RE - Diesel. All American RE - CNG. Micro Bird G5 - Gas/Diesel. Micro Bird G5 - Propane. Micro Bird MB-II - Gas/Diesel. Benefits of School Buses. All American FE - Diesel. All American RE - Diesel. All American RE - CNG. Micro Bird G5 - Gas/Diesel. Micro Bird G5 - Propane. Micro Bird MB-II - Gas/Diesel. Benefits of School Buses. News and Financial Reporting. News and Financial Reporting. Jefferies 11th Annual Industrials Conference Presentation. Fort Valley, GA 31030.

investors.blue222.com investors.blue222.com

Blue222.com › Log In

Larr; Back to Blue222.com.

investors.bmrn.com investors.bmrn.com

BioMarin Pharmaceutical Inc. - Investor Relations

Grants and Charitable Contributions. BioMarin Europe Ltd./BioMarin Latin America. BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the companys common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarins policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly. Aug 5, 2015 - Form S-8.

investors.bobevans.com investors.bobevans.com

Bob Evans - Investor Relations

Bob Evans Corporate Site. Dividend Reinvestment and Direct Stock Purchase Plan. Payroll Deduction Form for Employees. Bob Evans Farms, Inc. Bob Evans Reports Fiscal 2017 Second-Quarter Results and Updates Fiscal 2017 Guidance. Dec 5, 2016. Bob Evans Declares Quarterly Dividend. Nov 29, 2016. Unsubscribe from Investor Relations email alerts.

investors.bobst.com investors.bobst.com

BOBST Investors: Investors

Remuneration and nomination committee. 2015 first half-year results. STABLE VOLUMES AND IMPLEMENTATION OF PROFIT IMPROVEMENT MEASURES MITIGATE NEGATIVE IMPACT OF WEAK EURO. Bobst Group recorded a good first half-year 2015 despite the weak Euro. Sales amounted to CHF 524.7 million for the half-year, compared to CHF 560.5 million in the same period last year. Adjusted for negative currency effects, sales remained stable. Data provided by SIX Financial Information SA. Subscribe to our News Alerts.

investors.boeing.com investors.boeing.com

Boeing Company - Investors - Overview

MINIMUM 20 MINUTE DELAY. January 11, 2017. Boeing is a global, principled organization with core strengths in innovation, productivity and disciplined execution. Guided by integrity, our strong operational performance allows us to succeed in our business and for our stakeholders. Dennis A. Muilenburg. Chairman, President and Chief Executive Officer. Our opportunity for sustained top, bottom-line growth. More military aircraft and satellites. Jan 11, 5:00 PM ET. Privacy and Cookie Policy. Powered By Q4 Inc.

investors.boingo.com investors.boingo.com

Overview | Boingo Wireless, Inc.

Skip to main navigation. Global Wi-Fi access for people on the go. High-Speed Internet and TV for Military. DAS and Wi-Fi products for venues, carriers, OEMs. High engagement ads for high profile brands. Getting people connected wirelessly since 2001. Boingo is a thriving business built on sound fundamentals. We acquire long-term wireless rights at large venues, build networks at those venues, and then monetize the networks with a variety of retail and wholesale products. 12:29 AM EDT on Mar 30, 2018.

investors.bojangles.com investors.bojangles.com

Overview | Bojangles‘ Famous Chicken ‘n Biscuits

Employees In the Community. Real Estate Site Submission. Join Our E-Club More. Get a FREE Cheddar Bo Biscuit when you sign up, then tasty news, notes and offers every month after with the Bojangles’ E-Club. MANAGEMENT and BOARD OF DIRECTORS. Stock Quote and Chart See More. Press Releases See More. Jan 09, 2017. First-ever New Bojangles’ Restaurant Concept to Debut in Greenville, S.C. Dec 27, 2016. Bojangles’ Warms Up Winter, Introduces New Pulled Pork Bowl with Sweet-n-Smoky Sauce. Dec 05, 2016.